RNGCX
Price
$58.82
Change
-$2.11 (-3.46%)
Updated
Dec 18 closing price
RNPEX
Price
$64.62
Change
-$2.05 (-3.07%)
Updated
Dec 18 closing price
Ad is loading...

RNGCX vs RNPEX

Header iconRNGCX vs RNPEX Comparison
Open Charts RNGCX vs RNPEXBanner chart's image
American Funds New Economy R3
Price$58.82
Change-$2.11 (-3.46%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R4
Price$64.62
Change-$2.05 (-3.07%)
VolumeN/A
CapitalizationN/A
RNGCX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNGCX vs. RNPEX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNGCX is a Buy and RNPEX is a Buy.

FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 149B vs. RNGCX (34.6B). RNPEX pays higher dividends than RNGCX: RNPEX (0.83) vs RNGCX (0.00). RNGCX was incepted earlier than RNPEX: RNGCX (23 years) vs RNPEX (23 years). RNGCX is a more actively managed with annual turnover of: 39.00 vs. RNPEX (17.00). RNGCX (250) and RNPEX (250) have matching initial minimum investment requirements. RNPEX annual gain was more profitable for investors over the last year : 22.17 vs. RNGCX (13.62). RNPEX return over 5 years is better than : 45.56 vs. RNGCX (32.09).
RNGCXRNPEXRNGCX / RNPEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD13.48621.48363%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets34.6B149B23%
Annual Yield % from dividends0.000.83-
Returns for 1 year13.6222.1761%
Returns for 3 years1.997.2228%
Returns for 5 years32.0945.5670%
Returns for 10 years49.0376.0564%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVBF22.80-0.23
-1.00%
CVB Financial Corp
Z80.77-0.87
-1.07%
Zillow Group
SIGA6.09-0.09
-1.46%
SIGA Technologies
CXAI1.76-0.07
-3.83%
CXApp
GLMD3.01-0.26
-7.95%
Galmed Pharmaceuticals Ltd